- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- January 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- January 2026
- 180 Pages
Global
From €4058EUR$4,500USD£3,480GBP
- Report
- September 2026
- 191 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 180 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 197 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 180 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 196 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 199 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 182 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP

The Peptide market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and peptides. Peptides are short chains of amino acids that are used to treat a variety of diseases, including cancer, diabetes, and autoimmune disorders. Peptides are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Peptide market is highly competitive, with a number of companies offering a variety of products. Companies in the market are focused on developing and manufacturing peptides for therapeutic use, as well as providing services such as peptide synthesis and purification. Additionally, some companies are involved in the development of peptide-based drug delivery systems.
Notable companies in the Peptide market include Novo Nordisk, Merck, Sanofi, and Pfizer. Other companies include AbbVie, Amgen, and Genentech. Show Less Read more